1-11 of 11
Maria E. Vergara-Lluri
Close
Sort by
Journal Articles

Updated Outcomes in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Using Tyrosine Kinase Inhibitors Combined with the Modified University of Southern California (USC ALL) Regimen without Peg-Asparaginase in the Era of Novel Agents

Vincent Louie Louie Mendiola, Catherine Ly, Jennifer Wang, Thuy Bui, Jack Rodman, Amir Ali, Karrune Woan, Eric Tam, Maria E. Vergara-Lluri, Preet M. Chaudhary, Dan Douer, Abdullah Ladha, George Yaghmour
Journal: Blood
Blood (2022) 140 (Supplement 1): 11702–11704.
https://doi.org/10.1182/blood-2022-164836
Published: 2022
Journal Articles

Updated Comparison of Outcomes in Hispanic and Non-Hispanic Patients with Ph-Negative Acute Lymphoblastic Leukemia Using the Modified Pediatric-Based University of Southern California Acute Lymphoblastic Leukemia (USC ALL) Regimen in the Era of Novel Agents

Vincent Louie Mendiola, Catherine Ly, Jennifer Wang, Thuy Bui, Jack Rodman, Amir Ali, Karrune Woan, Eric Tam, Maria E. Vergara-Lluri, Preet M. Chaudhary, Dan Douer, Abdullah Ladha, George Yaghmour
Journal: Blood
Blood (2022) 140 (Supplement 1): 11685–11687.
https://doi.org/10.1182/blood-2022-167684
Published: 2022
Journal Articles

Updated Outcomes of the University of Southern California (USC) ALL Frontline Regimen (based on CCG-1882) after Protocol Modification in the Era of Novel Agents in Ph-Negative ALL Patients

Vincent Louie Ramos Mendiola, Catherine Ly, Jennifer Wang, Thuy Bui, Jack Rodman, Amir Ali, Maria E. Vergara-Lluri, Karrune Woan, Eric Tam, Preet M. Chaudhary, Dan Douer, Abdullah Ladha, George Yaghmour
Journal: Blood
Blood (2022) 140 (Supplement 1): 11668–11670.
https://doi.org/10.1182/blood-2022-167512
Published: 2022
Journal Articles

Characteristics and Outcomes for Adult Patients with T-Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL): A Retrospective Study

Julian Hardy McLain, Madeline Macdonald, Matthew Juarez, Han Tun, Upama Giri, Maria E. Vergara-Lluri, Imran Siddiqi, Zaw Win Myint
Journal: Blood
Blood (2022) 140 (Supplement 1): 11588–11589.
https://doi.org/10.1182/blood-2022-170735
Published: 2022
Journal Articles

Time to Diagnosis and Treatment in an Underserved, Predominantly Hispanic Population of Adults in East Los Angeles- a Retrospective Study of Acute T- Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL) Patients

Madeline Macdonald, Matthew Juarez, Julian Hardy McLain, Maria E. Vergara-Lluri, Imran Siddiqi, Upama Giri, Han Tun, Zaw Win Myint
Journal: Blood
Blood (2022) 140 (Supplement 1): 11598–11599.
https://doi.org/10.1182/blood-2022-158703
Published: 2022
Journal Articles

Survival and Outcomes after Relapse in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Treated with Venetoclax-Based Chemotherapy

Lydia D Chow, Denaly Chen, Maria E. Vergara-Lluri, Eric Tam, Karrune Woan, Preet M. Chaudhary, George Yaghmour, Abdullah Ladha
Journal: Blood
Blood (2022) 140 (Supplement 1): 9027–9028.
https://doi.org/10.1182/blood-2022-171127
Published: 2022
Journal Articles

An Update on Outcomes Using the USC ALL Frontline Regimen (based on CCG-1882) after Further Modification of Protocol in the Era of Novel Agents in Ph-Negative ALL Patients; A Retrospective Study

Vincent Louie Mendiola, Catherine Ly, Thuy Bui, Jennifer Wang, Jack Rodman, Maria E. Vergara-Lluri, Karrune Woan, Eric Tam, Preet M. Chaudhary, Dan Douer, Abdullah Ladha, George Yaghmour
Journal: Blood
Blood (2021) 138 (Supplement 1): 3362.
https://doi.org/10.1182/blood-2021-147124
Published: 2021
Journal Articles

Superior Outcomes in Hispanic Patients Compared to Non-Hispanic Patients with Ph-Negative Acute Lymphoblastic Leukemia Using the Modified Pediatric-Based University of Southern California Acute Lymphoblastic Leukemia (USC ALL) Regimen for Newly Diagnosed ALL Patients in the Era of Novel Agents; A Retrospective Study

Vincent Louie Ramos Mendiola, Catherine Ly, Thuy Bui, Jennifer Wang, Jack Rodman, Karrune Woan, Eric Tam, Maria E. Vergara-Lluri, Preet M. Chaudhary, Dan Douer, Abdullah Ladha, George Yaghmour
Journal: Blood
Blood (2021) 138 (Supplement 1): 3361.
https://doi.org/10.1182/blood-2021-150116
Published: 2021
Journal Articles

Outcomes in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Using Tyrosine Kinase Inhibitors Combined with the Modified University of Southern California (USC ALL) Regimen without Pegaspargase in the Era of Novel Agents; A Retrospective Study

Vincent Louie Ramos Mendiola, Catherine Ly, Thuy Bui, Jennifer Wang, Jack Rodman, Karrune Woan, Eric Tam, Maria E. Vergara-Lluri, Preet M. Chaudhary, Dan Douer, Abdullah Ladha, George Yaghmour
Journal: Blood
Blood (2021) 138 (Supplement 1): 4372.
https://doi.org/10.1182/blood-2021-150135
Published: 2021
Journal Articles

Prodromal / Pre-Leukemic Acute Leukemia of B-Lymphoblasts in 7 Adult Patients

Maria E. Vergara-Lluri, MD, Russell K Brynes, MD, Ashley Hagiya, MD, Sherif Rezk, MD, Darryl Shibata, MD, Ann Mohrbacher, MD, Imran Siddiqi, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-143455
Published: 2020
Journal Articles

Autoimmune Myelofibrosis (AIMF) – Clinical Features, Course and Outcome

Caroline Irene Piatek, M.D., Maria E. Vergara-Lluri, M.D., Vinod Pullarkat, MD, Imran N. Siddiqi, M.D, Ph.D., Casey O'Connell, MD, Donald I. Feinstein, MD, Russell K. Brynes, MD
Journal: Blood
Blood (2013) 122 (21): 3714.
https://doi.org/10.1182/blood.V122.21.3714.3714
Published: 2013